Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnny Ludvigsson

Showing results (11-20 of 376) with videos related to

Pageof 38
Sort By:
Lakartidningen|December 12, 2018
Johnny Ludvigsson
Pediatric Diabetes|August 9, 2019
No acute pancreatitis but reduced exocrine pancreatic function at diagnosis of type 1 diabetes in childrenJohnny Ludvigsson
Expert Opinion on Biological Therapy|May 9, 2017
GAD65: a prospective vaccine for treating Type 1 diabetes?Johnny Ludvigsson
Expert Review of Vaccines|March 3, 2012
In light of recent clinical trial results, what lies next for Type 1 diabetes vaccine research?Johnny Ludvigsson
Immunotherapy|June 28, 2017
Time to leave rigid traditions in Type 1 diabetes researchJohnny Ludvigsson
Journal of Diabetes Science and Technology|February 11, 2010
The role of immunomodulation therapy in autoimmune diabetesJohnny Ludvigsson,
Diabetes/Metabolism Research and Reviews|October 31, 2009
C-peptide an adequate endpoint in type 1 diabetesJohnny Ludvigsson
Diabetes Care|August 9, 2017
Increasing Incidence but Decreasing Awareness of Type 1 Diabetes in SwedenJohnny Ludvigsson
Lakartidningen|June 5, 2010
["Physicians who make public statements must consider their responsibility"]Johnny Ludvigsson
Current Diabetes Reports|July 30, 2010
Immune intervention in children with type 1 diabetesJohnny Ludvigsson,
Pageof 38

Showing results (11-20 of 376) with videos related to

Sort By:
Pageof 38
Lakartidningen|December 12, 2018
Johnny Ludvigsson
Pediatric Diabetes|August 9, 2019
No acute pancreatitis but reduced exocrine pancreatic function at diagnosis of type 1 diabetes in childrenJohnny Ludvigsson
Expert Opinion on Biological Therapy|May 9, 2017
GAD65: a prospective vaccine for treating Type 1 diabetes?Johnny Ludvigsson
Expert Review of Vaccines|March 3, 2012
In light of recent clinical trial results, what lies next for Type 1 diabetes vaccine research?Johnny Ludvigsson
Immunotherapy|June 28, 2017
Time to leave rigid traditions in Type 1 diabetes researchJohnny Ludvigsson
Journal of Diabetes Science and Technology|February 11, 2010
The role of immunomodulation therapy in autoimmune diabetesJohnny Ludvigsson,
Diabetes/Metabolism Research and Reviews|October 31, 2009
C-peptide an adequate endpoint in type 1 diabetesJohnny Ludvigsson
Diabetes Care|August 9, 2017
Increasing Incidence but Decreasing Awareness of Type 1 Diabetes in SwedenJohnny Ludvigsson
Lakartidningen|June 5, 2010
["Physicians who make public statements must consider their responsibility"]Johnny Ludvigsson
Current Diabetes Reports|July 30, 2010
Immune intervention in children with type 1 diabetesJohnny Ludvigsson,
Pageof 38